Back to News
Market Impact: 0.45

Do Options Traders Know Something About CareDx Stock We Don't?

CareDx, Inc.NDAQ
Derivatives & VolatilityFutures & OptionsCompany FundamentalsAnalyst EstimatesAnalyst InsightsCorporate EarningsInvestor Sentiment & PositioningHealthcare & Biotech
Do Options Traders Know Something About CareDx Stock We Don't?

CareDx (CDNA) saw its Nov 21, 2025 $2.50 Put options register among the highest implied volatility today, indicating market anticipation of a substantial price movement. This options market activity occurs despite a weak fundamental outlook for CareDx, which holds a Zacks Rank #4 (Sell) and has experienced a recent downward revision in its current quarter earnings consensus estimate from $0.15 to $0.14 per share, with no upward revisions. The notable divergence between high implied volatility and bearish analyst sentiment suggests a potential trading opportunity, particularly for options strategies like selling premium.

Analysis

The options market is signaling significant expected price movement for CareDx, Inc. (CDNA), evidenced by exceptionally high implied volatility in its November 21, 2025, $2.50 Put options. This market-implied volatility suggests investors are anticipating a major rally or sell-off. However, this expectation starkly contrasts with the company's deteriorating fundamental outlook. CareDx currently holds a Zacks Rank #4 (Sell) and operates within an industry segment ranked in the bottom 35%. This bearish sentiment is further substantiated by recent analyst actions; over the last 30 days, the Zacks Consensus Estimate for the current quarter's earnings per share was revised downward from 15 cents to 14 cents, following a negative revision from one analyst with no offsetting positive revisions. The divergence between the options market's pricing of a large move and the decidedly negative analyst sentiment suggests a potential setup for volatility-based trading strategies.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo